First patient dosed in trial for novel dry AMD treatment PST-611
7th July 2025 Uncategorised 0
PulseSight begins phase 1 safety study of gene therapy for geographic atrophy
More: First patient dosed in trial for novel dry AMD treatment PST-611
Source: News